Antiobesity Drugs Global Market Report 2019

Request Free Sample Buy Report

Antiobesity Drugs Global Market Report 2020 - By Drug Class (Peripherally Acting Anti Obesity Drugs, Centrally Acting Anti Obesity Drugs), By Type (Prescription Drugs (Rx), OTC Drugs), By Medication (Monotherapies, Polytherapies)

Antiobesity Drugs Global Market Report 2019

Starting Price : $4000.00 | Pages : 200 | Published : January 2020 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request Sample

Request For Discount

Customise Your Report

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The anti-obesity drugs market consists of sales of anti-obesity drugs and related services. This industry includes establishments that produce pharmacological agents that reduce or control overweight.

The global antiobesity market was valued at about $1.3 billion in 2018 and is expected to grow to $3.44 billion at a CAGR of 27.5% through 2022.

The anti-obesity drugs market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for anti-obesity drugs and is expected to continue to be the largest market during the forecast period.

Obesity is a major public health concern globally. Globally, prevalence rate of obesity is increasing every year. According to WHO, in 2016, more than 1.9 billion adults over the age of 18 years were overweight of which over 650 million were obese. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity and lack of awareness on the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving market growth.

Obesity is a major health problem worldwide which is caused from leading a sedentary lifestyle and consumption of unhealthy food. Though various anti-obesity drugs have been approved and are available in the USA, European Union, Australia, and Japan to treat obesity and overweight. It has been observed that these drugs have various adverse effects on patients undergoing treatment for obesity. Adverse effects include low blood pressure and blood glucose, incontinence, insomnia, nausea, diarrhea and others. For instance, Sibutramine and its combination drugs sold under various brands was recalled in various countries due to various side effects including heart attack in consumers. These factors restraint the growth of anti-obesity drugs market.

Pharmaceutical industry is witnessing an increase in the number of mergers and acquisition among companies developing drugs for metabolic disorders such as obesity, diabetes and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market. For instance, in 2018, Evotec AG and Novo Nordisk entered into a strategic alliance to be able to discover and develop drug molecules to treat metabolic disorders including obesity, diabetes and other associated disorders.

Major players in the anti-obesity drugs market are F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, and Pfizer Inc.

Table Of Contents

1. Executive Summary

2. Anti-obesity Drugs Market Characteristics

3. Anti-obesity Drugs Market Size And Growth

3.1. Global Anti-obesity Drugs Historic Market, 2014 - 2018, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Anti-obesity Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Anti-obesity Drugs Market Segmentation

4.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Peripherally acting anti obesity drugs

Centrally acting anti obesity drugs

4.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Prescription Drugs (Rx)

OTC Drugs

4.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Monotherapies

Polytherapies

5. Anti-obesity Drugs Market Regional And Country Analysis

5.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

5.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-obesity Drugs Market

6.1. Asia-Pacific Anti-obesity Drugs Market Overview

6.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

7. China Anti-obesity Drugs Market

7.1. China Anti-obesity Drugs Market Overview

7.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

7.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

8. India Anti-obesity Drugs Market

8.1. India Anti-obesity Drugs Market Overview

8.2. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

8.3. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9. Japan Anti-obesity Drugs Market

9.1. Japan Anti-obesity Drugs Market Overview

9.2. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9.3. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10. Australia Anti-obesity Drugs Market

10.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Anti-obesity Drugs Market

11.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12. South Korea Anti-obesity Drugs Market

12.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Anti-obesity Drugs Market

13.1. Western Europe Anti-obesity Drugs Market Overview

13.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14. UK Anti-obesity Drugs Market

14.1. UK Anti-obesity Drugs Market Overview

14.2. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14.3. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15. Germany Anti-obesity Drugs Market

15.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16. France Anti-obesity Drugs Market

16.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-obesity Drugs Market

17.1. Eastern Europe Anti-obesity Drugs Market Overview

17.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18. Russia Anti-obesity Drugs Market

18.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19. North America Anti-obesity Drugs Market

19.1. North America Anti-obesity Drugs Market Overview

19.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20. USA Anti-obesity Drugs Market

20.1. USA Anti-obesity Drugs Market Overview

20.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21. South America Anti-obesity Drugs Market

21.1. South America Anti-obesity Drugs Market Overview

21.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22. Brazil Anti-obesity Drugs Market

22.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23. Middle East Anti-obesity Drugs Market

23.1. Middle East Anti-obesity Drugs Market Overview

23.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24. Africa Anti-obesity Drugs Market

24.1. Africa Anti-obesity Drugs Market Overview

24.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

25. Anti-obesity Drugs Market Competitive Landscape And Company Profiles

25.1. Anti-obesity Drugs Market Competitive Landscape

25.2. Anti-obesity Drugs Market Company Profiles

25.2.1. F. Hoffmann-La Roche AG,

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. GlaxoSmithKline PLC,

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Boehringer Ingelheim GmbH,

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Pfizer Inc.,

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Merck & Co. Inc.,

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-obesity Drugs Market

27. Anti-obesity Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-obesity Drugs Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations

30.2. Currencies

30.3. Research Inquiries

30.4. The Business Research Company

30.5. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 46: F. Hoffmann-La Roche AG, Financial Performance

Table 47: GlaxoSmithKline PLC, Financial Performance

Table 48: Boehringer Ingelheim GmbH, Financial Performance

Table 49: Pfizer Inc., Financial Performance

Table 50: Merck & Co. Inc., Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2014-2018, $ Billion

Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Figure 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 46: F. Hoffmann-La Roche AG, Financial Performance

Figure 47: GlaxoSmithKline PLC, Financial Performance

Figure 48: Boehringer Ingelheim GmbH, Financial Performance

Figure 49: Pfizer Inc., Financial Performance

Figure 50: Merck & Co. Inc., Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Microbiome Global Market Report 2024 – By Type (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Technology (Genomics, Proteomics, Metabolomics), By End-Use (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the antiobesity drugs market?

How will the antiobesity drugs market drivers and restraints affect antiobesity drugs market dynamics? What forces will shape the antiobesity drugs industry going forward?

The anti-obesity drugs market growth is aided by the prevalence rate of obesity. request a sample here

What is the forecast market size of the antiobesity drugs market?

The anti-obesity drugs market forecast is expected to reach $3.44 billion in 2022 at a compound annual growth rate of 27.5%. request a sample here

How is the antiobesity drugs market segmented?

request a sample here

Which region has largest share, and what is the market size and growth by geography according to the antiobesity drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global antiobesity drugs market?

Top competitors in the anti--obesity drugs market are F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, and Pfizer Inc. request a sample here.

What are the key trends in the global antiobesity drugs market?

Major trends influencing the anti-obesity drugs market include increase in the number of mergers and acquisition among companies developing drugs for metabolic disorders such as obesity, diabetes and others request a sample here.

What are the major opportunities in the antiobesity drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global antiobesity drugs market, request a sample here.

How does the antiobesity drugs market relate to the overall economy and other similar markets?

request a sample here.